Corrigendum: The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

• Anna L. Beukenhorst,
• Anna L. Beukenhorst,
• Jacopo Frallicciardi,
• Clarissa M. Koch,
• Jaco M. Klap,
• Angela Phillips,
• Michael M. Desai,
• Kanin Wichapong,
• Gerry A. F. Nicolaes,
• Wouter Koudstaal,
• Galit Alter,
• Galit Alter,
• Jaap Goudsmit,
• Jaap Goudsmit

Affiliations

Anna L. Beukenhorst

Leyden Laboratories B.V., Amsterdam, Netherlands

Anna L. Beukenhorst

Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, United States

Jacopo Frallicciardi

Leyden Laboratories B.V., Amsterdam, Netherlands

Clarissa M. Koch

Leyden Laboratories B.V., Amsterdam, Netherlands

Jaco M. Klap

Leyden Laboratories B.V., Amsterdam, Netherlands

Angela Phillips

Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, United States

Michael M. Desai

Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, United States

Kanin Wichapong

Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands

Gerry A. F. Nicolaes

Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands

Wouter Koudstaal

Leyden Laboratories B.V., Amsterdam, Netherlands

Galit Alter

Leyden Laboratories B.V., Amsterdam, Netherlands

Galit Alter

Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard, Cambridge, MA, United States

Jaap Goudsmit

Leyden Laboratories B.V., Amsterdam, Netherlands

Jaap Goudsmit

Departments of Epidemiology, Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, United States